줄기세포 제조 시장(2026-2030년)

The global stem cell manufacturing market is forecasted to grow by USD 8305.6 mn during 2025-2030, accelerating at a CAGR of 10.0% during the forecast period. The report on the global stem cell manufacturing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise of contract manufacturing organizations, rising prevalence of chronic diseases, expansion of regenerative medicine investments.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global stem cell manufacturing market is segmented as below:

By End-User

• P and BC
• AI RL and CRO
• Hospitals and surgical centres
• Cell and tissue banks
• Others

By Product Type

• Consumables
• Culture media
• Instruments
• Services
• Stem cell lines

By Application

• Stem cell therapy
• Stem cell banking
• Drug discovery and toxicology
• Tissue engineering and regenerative medicine

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the advancements in automated closed-system bioreactors as one of the prime reasons driving the global stem cell manufacturing market growth during the next few years. Also, expansion of stem cell banking infrastructure and adoption of gene editing technologies will lead to sizable demand in the market.

The report on the global stem cell manufacturing market covers the following areas:

• Global stem cell manufacturing market sizing
• Global stem cell manufacturing market forecast
• Global stem cell manufacturing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global stem cell manufacturing market vendors that include Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio Techne Corp., Charles River Laboratories, Corning Inc., Cytiva, Eppendorf SE, FUJIFILM Holdings Corp., Getinge AB, HiMedia Laboratories Pvt. Ltd., Lonza Group Ltd., Made Scientific, Merck KGaA, Miltenyi Biotec BV and Co. KG, OmniAb Inc., PromoCell GmbH, Sartorius AG, STEMCELL Technologies Inc., Takara Bio Inc., Terumo Corp., Thermo Fisher Scientific Inc.. Also, the global stem cell manufacturing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Product Type
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Stem Cell Manufacturing Market 2020 - 2024
  • Historic Market Size - Data Table on Global Stem Cell Manufacturing Market 2020 - 2024 ($ million)
• 5.2 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.3 Product Type segment analysis 2020 - 2024
  • Historic Market Size - Product Type Segment 2020 - 2024 ($ million)
• 5.4 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Stem Cell Manufacturing Market
• 6.2 Impact of geopolitical conflicts on Global Stem Cell Manufacturing Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by End-user

• 8.1 Market segments
• 8.2 Comparison by End-user
• 8.3 P and BC - Market size and forecast 2025-2030
• 8.4 AI RL and CRO - Market size and forecast 2025-2030
• 8.5 Hospitals and surgical centres - Market size and forecast 2025-2030
• 8.6 Cell and tissue banks - Market size and forecast 2025-2030
• 8.7 Others - Market size and forecast 2025-2030
• 8.8 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

9 Market Segmentation by Product Type

• 9.1 Market segments
• 9.2 Comparison by Product Type
• 9.3 Consumables - Market size and forecast 2025-2030
• 9.4 Culture media - Market size and forecast 2025-2030
• 9.5 Instruments - Market size and forecast 2025-2030
• 9.6 Services - Market size and forecast 2025-2030
• 9.7 Stem cell lines - Market size and forecast 2025-2030
• 9.8 Market opportunity by Product Type
  • Market opportunity by Product Type ($ million)

10 Market Segmentation by Application

• 10.1 Market segments
• 10.2 Comparison by Application
• 10.3 Stem cell therapy - Market size and forecast 2025-2030
• 10.4 Stem cell banking - Market size and forecast 2025-2030
• 10.5 Drug discovery and toxicology - Market size and forecast 2025-2030
• 10.6 Tissue engineering and regenerative medicine - Market size and forecast 2025-2030
• 10.7 Market opportunity by Application
  • Market opportunity by Application ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 India - Market size and forecast 2025-2030
  • 12.5.3 Japan - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 Colombia - Market size and forecast 2025-2030
  • 12.6.7 South Africa - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rise of contract manufacturing organizations
  • Rising prevalence of chronic diseases
  • Expansion of regenerative medicine investments
• 13.2 Market challenges
  • Advancements in automated closed-system bioreactors
  • Expansion of stem cell banking infrastructure
  • Adoption of gene editing technologies
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Advancements in automated closed-system bioreactors
  • Expansion of stem cell banking infrastructure
  • Adoption of gene editing technologies

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Becton Dickinson and Co.
  • Becton Dickinson and Co. - Overview
  • Becton Dickinson and Co. - Business segments
  • Becton Dickinson and Co. - Key news
  • Becton Dickinson and Co. - Key offerings
  • Becton Dickinson and Co. - Segment focus
  • SWOT
• 15.5 Bio Rad Laboratories Inc.
  • Bio Rad Laboratories Inc. - Overview
  • Bio Rad Laboratories Inc. - Business segments
  • Bio Rad Laboratories Inc. - Key news
  • Bio Rad Laboratories Inc. - Key offerings
  • Bio Rad Laboratories Inc. - Segment focus
  • SWOT
• 15.6 Bio Techne Corp.
  • Bio Techne Corp. - Overview
  • Bio Techne Corp. - Business segments
  • Bio Techne Corp. - Key news
  • Bio Techne Corp. - Key offerings
  • Bio Techne Corp. - Segment focus
  • SWOT
• 15.7 Charles River Laboratories
  • Charles River Laboratories - Overview
  • Charles River Laboratories - Business segments
  • Charles River Laboratories - Key offerings
  • Charles River Laboratories - Segment focus
  • SWOT
• 15.8 Corning Inc.
  • Corning Inc. - Overview
  • Corning Inc. - Business segments
  • Corning Inc. - Key offerings
  • Corning Inc. - Segment focus
  • SWOT
• 15.9 FUJIFILM Holdings Corp.
  • FUJIFILM Holdings Corp. - Overview
  • FUJIFILM Holdings Corp. - Business segments
  • FUJIFILM Holdings Corp. - Key news
  • FUJIFILM Holdings Corp. - Key offerings
  • FUJIFILM Holdings Corp. - Segment focus
  • SWOT
• 15.10 Getinge AB
  • Getinge AB - Overview
  • Getinge AB - Business segments
  • Getinge AB - Key offerings
  • Getinge AB - Segment focus
  • SWOT
• 15.11 Lonza Group Ltd.
  • Lonza Group Ltd. - Overview
  • Lonza Group Ltd. - Business segments
  • Lonza Group Ltd. - Key news
  • Lonza Group Ltd. - Key offerings
  • Lonza Group Ltd. - Segment focus
  • SWOT
• 15.12 Merck KGaA
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key news
  • Merck KGaA - Key offerings
  • Merck KGaA - Segment focus
  • SWOT
• 15.13 OmniAb Inc.
  • OmniAb Inc. - Overview
  • OmniAb Inc. - Product / Service
  • OmniAb Inc. - Key offerings
  • SWOT
• 15.14 PromoCell GmbH
  • PromoCell GmbH - Overview
  • PromoCell GmbH - Product / Service
  • PromoCell GmbH - Key offerings
  • SWOT
• 15.15 Sartorius AG
  • Sartorius AG - Overview
  • Sartorius AG - Business segments
  • Sartorius AG - Key offerings
  • Sartorius AG - Segment focus
  • SWOT
• 15.16 Takara Bio Inc.
  • Takara Bio Inc. - Overview
  • Takara Bio Inc. - Product / Service
  • Takara Bio Inc. - Key offerings
  • SWOT
• 15.17 Terumo Corp.
  • Terumo Corp. - Overview
  • Terumo Corp. - Business segments
  • Terumo Corp. - Key news
  • Terumo Corp. - Key offerings
  • Terumo Corp. - Segment focus
  • SWOT
• 15.18 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations